aod9604 clinical trial weight loss results AOD-9604 | CAS#221231-10-3 Variant:5mg 5-Amino 1MQ 50mg (60 B12 injection for anemia

aod9604 clinical trial weight loss results AOD-9604 | CAS#221231-10-3 Variant:5mg 5-Amino 1MQ 50mg (60 B12 injection for anemia

5-Amino 1MQ 50mg (60 capsules) – Paragon Pharmatech

Sci., 2015

B12 injection for anemia

Variant:5mg

As a selective substrate site-targeting inhibitor of nicotinamide N-methyltransferase (NNMT) — the cytosolic enzyme responsible for the methylation of nicotinamide using S-adenosylmethionine (SAM) as a methyl donor — 5-Amino-1MQ is studied as a tool compound for investigating NNMT enzyme activity, NAD⁺ salvage pathway interactions, and methylation pathway dynamics in controlled in-vitro experimental systems